315 related articles for article (PubMed ID: 28341067)
21. Efficacy and safety of collagenase treatment for Dupuytren's disease: 2-year follow-up results.
Van Beeck A; Van den Broek M; Michielsen M; Didden K; Vuylsteke K; Verstreken F
Hand Surg Rehabil; 2017 Oct; 36(5):346-349. PubMed ID: 28732844
[TBL] [Abstract][Full Text] [Related]
22. Analysis of efficacy and safety of treatment with collagenase Clostridium histolyticum among subgroups of patients with Dupuytren contracture.
Raven RB; Kushner H; Nguyen D; Naam N; Curtin C
Ann Plast Surg; 2014 Sep; 73(3):286-90. PubMed ID: 23511746
[TBL] [Abstract][Full Text] [Related]
23. Adverse effects associated with collagenase clostridium histolyticum in Dupuytren disease: A prospective study.
Sanjuan-Cerveró R; Carrera-Hueso FJ; Vazquez-Ferreiro P
Orthop Traumatol Surg Res; 2018 Oct; 104(6):901-905. PubMed ID: 30253866
[TBL] [Abstract][Full Text] [Related]
24. Five-year results after collagenase treatment of Dupuytren disease.
Werlinrud JC; Hansen KL; Larsen S; Lauritsen J
J Hand Surg Eur Vol; 2018 Oct; 43(8):841-847. PubMed ID: 30071789
[TBL] [Abstract][Full Text] [Related]
25. Short-term efficacy and safety of collagenase injection for Dupuytren's contracture: Therapy protocol for successful outcomes in a clinical setting.
Sakai A; Zenke Y; Menuki K; Yamanaka Y; Tajima T; Tsukamoto M; Uchida S
J Orthop Sci; 2019 May; 24(3):434-440. PubMed ID: 30392714
[TBL] [Abstract][Full Text] [Related]
26. Efficacy and safety of collagenase Clostridium histolyticum injection for Dupuytren contracture: report of 40 cases.
Alberton F; Corain M; Garofano A; Pangallo L; Valore A; Zanella V; Adani R
Musculoskelet Surg; 2014 Dec; 98(3):225-32. PubMed ID: 24254968
[TBL] [Abstract][Full Text] [Related]
27. Multiple concurrent collagenase clostridium histolyticum injections to Dupuytren's cords: an exploratory study.
Coleman S; Gilpin D; Tursi J; Kaufman G; Jones N; Cohen B
BMC Musculoskelet Disord; 2012 Apr; 13():61. PubMed ID: 22540636
[TBL] [Abstract][Full Text] [Related]
28. Range of motion, postoperative rehabilitation and patient satisfaction in MCP and PIP joints affected by Dupuytren Tubiana stage 1-3: collagenase enzymatic fasciotomy or limited fasciectomy? A clinical study in 52 patients.
Leclère FM; Kohl S; Varonier C; Unglaub F; Vögelin E
Arch Orthop Trauma Surg; 2018 Nov; 138(11):1623-1631. PubMed ID: 30259125
[TBL] [Abstract][Full Text] [Related]
29. Collagenase Treatment for Dupuytren Disease of the Thumb and First Web.
Dreise MM; Stenekes MW; Werker PM
J Hand Surg Am; 2016 Mar; 41(3):348-53.e1. PubMed ID: 26803569
[TBL] [Abstract][Full Text] [Related]
30. The Impact of Collagenase Clostridium histolyticum Introduction on Dupuytren Treatment Patterns in the United States.
Zhao JZ; Hadley S; Floyd E; Earp BE; Blazar PE
J Hand Surg Am; 2016 Oct; 41(10):963-968. PubMed ID: 27546441
[TBL] [Abstract][Full Text] [Related]
31. Effectiveness and safety of collagenase Clostridium histolyticum in Dupuytren's disease : an observational study in Belgium.
Verstreken F; Degreef I; Decramer A; Libberecht K; Vanhove W; Datco A; Vanhaecke J; Clermont D; Duerinckx J
Acta Orthop Belg; 2016 Aug; 82(2):397-404. PubMed ID: 27682305
[TBL] [Abstract][Full Text] [Related]
32. Risk Factors for Skin Tears Following Collagenase Clostridium histolyticum to Treat Dupuytren Contractures.
Wei DH; Cantlon MB; Wakefield DB; Vitale MA
J Hand Surg Am; 2020 Oct; 45(10):989.e1-989.e10. PubMed ID: 32546304
[TBL] [Abstract][Full Text] [Related]
33. Salvage palmar fasciectomy after initial treatment with collagenase clostridium histolyticum.
Eberlin KR; Kobraei EM; Nyame TT; Bloom JM; Upton J
Plast Reconstr Surg; 2015 Jun; 135(6):1000e-1006e. PubMed ID: 26017606
[TBL] [Abstract][Full Text] [Related]
34. [Collagenase Clostridum histolyticum in the management of Dupuytren's contracture].
Holzer LA; Holzer G
Handchir Mikrochir Plast Chir; 2011 Oct; 43(5):269-74. PubMed ID: 21935843
[TBL] [Abstract][Full Text] [Related]
35. Pain Associated With Treatment of Dupuytren Contracture With Collagenase Clostridium histolyticum.
Sanjuan-Cerveró R; Carrera-Hueso FJ; Vazquez-Ferreiro P; Fikri-Benbrahim N; Franco-Ferrando N; Peimer CA
J Hand Surg Am; 2017 Feb; 42(2):e109-e114. PubMed ID: 28160905
[TBL] [Abstract][Full Text] [Related]
36. Collagenase Tenotomy for Dupuytren Boutonniere.
Denkler KA; Vaughn CJ; Park KM; Hansen SL
Plast Reconstr Surg; 2021 Nov; 148(5):764e-768e. PubMed ID: 34705780
[TBL] [Abstract][Full Text] [Related]
37. Efficacy and safety of collagenase clostridium histolyticum for Dupuytren disease nodules: a randomized controlled trial.
Costas B; Coleman S; Kaufman G; James R; Cohen B; Gaston RG
BMC Musculoskelet Disord; 2017 Aug; 18(1):374. PubMed ID: 28854973
[TBL] [Abstract][Full Text] [Related]
38. Development of Collagenase Treatment for Dupuytren Disease.
Badalamente MA; Hurst LC
Hand Clin; 2018 Aug; 34(3):345-349. PubMed ID: 30012294
[TBL] [Abstract][Full Text] [Related]
39. Outcomes and Early Recurrence Following Enzymatic (Collagenase) Treatment of Moderate and Severe Dupuytren Contractures.
David M; Smith G; Pinder R; Craigen M; Waldram M; Mishra A; Dickson D; Wu F; Brewster M
J Hand Surg Am; 2020 Dec; 45(12):1187.e1-1187.e11. PubMed ID: 32861504
[TBL] [Abstract][Full Text] [Related]
40. Efficacy and safety of injectable mixed collagenase subtypes in the treatment of Dupuytren's contracture.
Badalamente MA; Hurst LC
J Hand Surg Am; 2007; 32(6):767-74. PubMed ID: 17606053
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
